SB 718

  • Wisconsin Senate Bill
  • 2023-2024 Regular Session
  • Introduced in Senate Nov 21, 2023
  • Senate
  • Assembly
  • Governor

Relating to: creating a Prescription Drug Affordability Review Board, funding for an office of prescription drug affordability, crediting certain amounts to the general program operations account of the office of the commissioner of insurance, granting rulemaking authority, and making an appropriation. (FE)

Votes


No votes to display

Actions


Apr 15, 2024

Senate

Failed to pass pursuant to Senate Joint Resolution 1

Dec 14, 2023

Senate

Fiscal estimate received

Dec 04, 2023

Senate

Representative Madison added as a cosponsor

Nov 27, 2023

Senate

Representative Haywood added as a cosponsor

Nov 21, 2023

Senate

Introduced by Senators Pfaff, Hesselbein, Agard, Carpenter, L. Johnson, Larson, Roys, Smith, Spreitzer, Taylor and Wirch; cosponsored by Representatives Subeck, C. Anderson, J. Anderson, Andraca, Bare, Billings, Clancy, Conley, Considine, Drake, Emerson, Hong, Jacobson, Joers, Moore Omokunde, Neubauer, Ortiz-Velez, Palmeri, Ratcliff, Shankland, Shelton and Sinicki

Senate

Read first time and referred to Committee on Health

Bill Text

Bill Text Versions Format
Bill Text PDF HTML

Related Documents

Document Format
2023 Assembly Bill 747 HTML
Wisconsin Ethics Commission information HTML
SB718 ROCP for Committee on Health HTML
SB718: Fiscal Estimate From OCI

Sources

Data on Open States is updated periodically throughout the day from the official website of the Wisconsin State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.